(IN BRIEF) Amey’s restoration project of the historic Chetwyn bridge in Staffordshire has received multiple industry awards. The Grade II* listed road bridge, the largest surviving pre-1830s cast iron bridge in England, underwent meticulous repairs to its ironwork and paintwork. … Read the full press release
Posted in Awards, Construction, Industrial, Infrastructure & Utilities, Management, United Kingdom
Tagged Alrewas, Amey, Bridge, cast iron Chetwyn bridge, CIHT West Midlands awards, David Williams, IHE Mercia Branch Awards, pre:1830s cast iron bridge, restoration, Richard Harris, road bridge, Staffordshire County Council, Staffordshire Grade II*
(IN BRIEF) Staffordshire County Council has extended its contract with highways’ partner Amey for another five years, with an extra £30m for the next two years to invest in the county’s highways network. As part of the contract extension, Amey … Read the full press release
Posted in Business, Construction, Infrastructure & Utilities, Investment, Management, News, United Kingdom
Tagged Amey, David Williams, highways, investment, partnership, Peter Anderson, Staffordshire, UK
(IN BRIEF) A new spin-out drug discovery company from the University of Liverpool called Sulantrix is exploring new cancer medicines targeting previously untapped classes of pseudoenzymes. The company is led by Professor Patrick Eyers and CEO David Williams, who has … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AI, Cancer, David Williams, Dr Emma Fairweather, drug discovery, Emma Nolan, Enterprise Investment Funding, ISMIB, Multi-omics Platforms, Professor Anthony Hollander, Professor Patrick Eyers, pseudoenzymes, spin-out, Sulantrix, University of Liverpool
(ACTUALITÉ EN BREF) Une nouvelle société dérivée de découverte de médicaments de l’Université de Liverpool appelée Sulantrix explore de nouveaux médicaments contre le cancer ciblant des classes de pseudoenzymes jusqu’alors inexploitées. La société est dirigée par le professeur Patrick Eyers … Read the full press release
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Cancer, David Williams, découverte de médicaments, Dr Emma Fairweather, Emma Nolan, essaimage, financement des investissements d'entreprise, IA, ISMIB, plateformes multi-omiques, professeur Anthony Hollander, professeur Patrick Eyers, pseudoenzymes, Sulantrix, Université de Liverpool
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
